<it>In vitro </it>cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against <it>Candida albicans</it>, human monocytic and kidney cell lines

<it>In vitro </it>cytotoxicity of two novel oral formulations of Amphotericin B (iCo-009 and iCo-010) against <it>Candida albicans</it>, human monocytic and kidney cell lines

<p>Abstract</p> <p>Background</p> <p>Invasive fungal infections such as candidiasis constitute an increasingly important medical problem. Drugs currently used for the treatment of candidiasis include polyenes (such as Amphotericin B) and azoles. Amphotericin B (AmpB) pr...

Full description

Bibliographic Details
Main Authors: Clement John G, Zhao Jinying, Wasan Ellen K, Gershkovich Pavel, Bartlett Karen, Lee Jinkyung, Leon Carlos G, Wasan Kishor M
Format: Article
Language:English
Published: BMC 2011-08-01
Series:Lipids in Health and Disease
Subjects:
Amphotericin B
Candida
cytotoxicity
monocytes.
Online Access:http://www.lipidworld.com/content/10/1/144

Internet

http://www.lipidworld.com/content/10/1/144

Similar Items